| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 7.48▲ | 7.46▲ | 7.45▲ | 7.64▼ | 8.24▼ |
| MA10 | 7.48▲ | 7.43▲ | 7.47▲ | 7.98▼ | 8.55▼ |
| MA20 | 7.46▲ | 7.46▲ | 7.52▼ | 8.45▼ | 8.35▼ |
| MA50 | 7.43▲ | 7.53▼ | 7.86▼ | 8.66▼ | 10.26▼ |
| MA100 | 7.45▲ | 7.89▼ | 8.13▼ | 8.51▼ | 11.29▼ |
| MA200 | 7.50▲ | 8.19▼ | 8.71▼ | 10.21▼ | 20.47▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.001▲ | 0.015▲ | 0.022▲ | -0.120▼ | 0.000▲ |
| RSI | 62.995▲ | 51.740▲ | 41.930▼ | 29.601▼ | 36.042▼ |
| STOCH | 54.215 | 62.679 | 42.347 | 20.389 | 36.094 |
| WILL %R | -11.765▲ | -15.625▲ | -30.769 | -90.997▼ | -94.118▼ |
| CCI | 113.914▲ | 123.265▲ | 41.750 | -135.716▼ | -146.749▼ |
|
Monday, September 28, 2026 04:59 PM
The Option Award and RSU Award were each granted as of September 28, 2026 (the “Grant Date”) in accordance with Nasdaq Listing Rule 5635(c)(4) and not pursuant to Arvinas’ stock incentive plan. The ...
|
|
Monday, September 28, 2026 04:59 PM
The Option Award and RSU Award were each granted as of September 28, 2026 (the “Grant Date”) in accordance with Nasdaq Listing Rule 5635(c)(4) and not pursuant to Arvinas’ stock incentive plan. The ...
|
|
Monday, September 28, 2026 05:42 AM
Arvinas (NASDAQ:ARVN) doses first participant in Phase 1/2 ARV-6723 trial for advanced solid tumors and immuno-oncology research.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 29/09/26 | 7.49 | 7.52 | 7.36 | 7.50 | 496,012 |
| 28/09/26 | 7.54 | 7.565 | 7.38 | 7.51 | 512,058 |
| 25/09/26 | 7.78 | 7.81 | 7.535 | 7.59 | 713,363 |
| 24/09/26 | 7.81 | 7.819 | 7.39 | 7.79 | 1,218,007 |
| 23/09/26 | 8.60 | 8.64 | 7.815 | 7.83 | 761,233 |
| 22/09/26 | 8.37 | 8.57 | 8.30 | 8.51 | 685,412 |
| 21/09/26 | 8.37 | 8.44 | 8.21 | 8.30 | 639,834 |
| 18/09/26 | 8.29 | 8.35 | 8.1901 | 8.29 | 1,775,827 |
| 17/09/26 | 8.29 | 8.46 | 8.17 | 8.31 | 532,853 |
| 16/09/26 | 8.31 | 8.325 | 8.05 | 8.16 | 742,605 |
|
|
||||
|
|
||||
|
|